Shorter cycles do not allow enough time for dose titration, steady-state achievement, and meaningful therapeutic effect
Regulatory status Cerebrolysin is approved for clinical use in over 45 countries, primarily in Europe and Asia
Focus your energy where it actually changes the bill: prior authorizations and diagnosis coding, comparing pharmacy prices by NDC, and asking your provider about clinically appropriate, lower-cost alternatives
Trial participants had already undergone a median of four prior anticancer therapies
Yet another aspect of the invention is to provide a method for increased temporal duration of the therapeutic response in treatment of sexual dysfunction by oral administration of a PDE-5 inhibitor and non-oral administration, preferably IN administration, of a melanocortin receptor agonist, preferably PT-141